Tabibiazar; Raymond

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tabibiazar; Raymond.The latest application filed is for "inhibition of axl/gas6 signaling in the treatment of liver fibrosis".

Company Profile

1.8.15

Tabibiazar; Raymond - Portola Valley CA
Tabibiazar; Raymond - Menlo Park CA
Tabibiazar; Raymond - Stanford CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antifibrotic activity of GAS6 inhibitor Grant 10,876,176 - Tabibiazar , et al. December 29, 2	2020-12-29
Antiviral activity of Gas6 inhibitor Grant 10,137,173 - Tabibiazar November 27, 2	2018-11-27
Inhibition Of Axl/gas6 Signaling In The Treatment Of Liver Fibrosis App 20180094034 - O'Connor; Patrick ; et al.	2018-04-05
Antifibrotic Activity Of Gas6 Inhibitor App 20180057898 - Tabibiazar; Raymond ; et al.	2018-03-01
Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis Grant 9,879,061 - O'Connor , et al. January 30, 2	2018-01-30
Antiviral Activity Of Gas6 Inhibitor App 20160206705 - Tabibiazar; Raymond	2016-07-21
Synthetic lethal targeting of glucose transport Grant 9,079,859 - Irwin , et al. July 14, 2	2015-07-14
Method for the treatment of acquired lymphedema Grant 8,965,708 - Tabibiazar , et al. February 24, 2	2015-02-24
Synthetic Lethal Targeting Of Glucose Transport App 20140128397 - Irwin; John ; et al.	2014-05-08
Inhibition of AXL/GAS6 Signaling in the Treatment of Disease App 20130189254 - O'Connor; Patrick ; et al.	2013-07-25
Lymphedema associated genes and model App 20120076731 - Tabibiazar; Raymond ; et al.	2012-03-29
Methods And Compositions For Diagnosis, Monitoring And Development Of Therapeutics For Treatment Of Atherosclerotic Disease App 20090305903 - TABIBIAZAR; Raymond ; et al.	2009-12-10
Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque Grant 7,495,024 - Tabibiazar , et al. February 24, 2	2009-02-24
Two Biomarkers For Diagnosis And Monitoring Of Atherosclerotic Cardiovascular Disease App 20080300797 - TABIBIAZAR; Raymond ; et al.	2008-12-04
Lymphedema associated genes and model App 20080051644 - Tabibiazar; Raymond ; et al.	2008-02-28
Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque App 20080033034 - Tabibiazar; Raymond ; et al.	2008-02-07
Atherosclerosis genes and related reagents and methods of use thereof App 20070253901 - Deng; David ; et al.	2007-11-01
Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease App 20070099239 - Tabibiazar; Raymond ; et al.	2007-05-03
Methods and compositions for diagnosis, monitoring and development of therapeutics for treatment of atherosclerotic disease App 20070092886 - Tabibiazar; Raymond ; et al.	2007-04-26
Cardiac pressure overload associated genes App 20060094038 - Wagner; Roger A. ; et al.	2006-05-04

Company Registrations

SEC

0001753279

Tabibiazar Raymond

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.